Carboplatin is a platinum compound that is preferred to cisplatin by virtue of its better toxicity profile. In combination with paclitaxel, carboplatin is a gold standard for treatment of advanced ovarian cancer. AUC dosing (commonly 4-6) is generally preferred to body surface area (BSA) dosing. With a much less renal toxicity than cisplatin, a vigorous hydration schedule or forced dieresis is not required with carboplatin.
Indications:
Generic Name | Strength | Standard | Type | Packing | Pack Size |
Carboplatin | 150 mg | BP | INJ | Vial | 15ml |
Carboplatin | 450 mg | BP | INJ | Vial | 45ml |